Arkema S.A. (OTCMKTS:ARKAY) Short Interest Up 400.0% in August

Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) was the target of a large increase in short interest in August. As of August 15th, there was short interest totalling 500 shares, an increase of 400.0% from the July 31st total of 100 shares. Based on an average daily volume of 2,700 shares, the short-interest ratio is currently 0.2 days.

ARKAY stock traded down $0.98 during midday trading on Friday, hitting $101.02. The stock had a trading volume of 319 shares, compared to its average volume of 1,143. The firm has a market cap of $7.58 billion, a PE ratio of 14.37, a price-to-earnings-growth ratio of 3.22 and a beta of 1.41. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.20 and a quick ratio of 1.59. Arkema has a 12-month low of $67.88 and a 12-month high of $109.19. The company's 50-day moving average price is $100.07 and its 200 day moving average price is $97.85.

Arkema (OTCMKTS:ARKAY - Get Free Report) last released its earnings results on Friday, July 28th. The basic materials company reported $3.00 EPS for the quarter. The firm had revenue of $2.66 billion during the quarter. Arkema had a net margin of 4.98% and a return on equity of 9.59%. On average, equities research analysts predict that Arkema will post 9.81 earnings per share for the current fiscal year.

Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates through Adhesive Solutions, Advanced Materials, Coating Solutions, and Intermediates segments. It also provides adhesive solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Before you consider Arkema, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.

While Arkema currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.